A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants With Alzheimer's Disease
NCT05744401 · TERMINATED · Phase 2
We track 1 ClinicalTrials.gov studies led by Alector Inc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Alector Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Alector Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Alector Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.